Tag:
Otsuka Pharmaceutical
Latest Headlines
Latest Headlines
FDA accepts Otsuka's app for long-lasting Abilify
Otsuka Pharmaceutical has taken an important step forward in the development of a once-monthly version of its blockbuster schizophrenia drug Abilify (aripiprazole). U.S. regulators have accepted for...
Bloomberg: Japan's Otsuka gets set for IPO
Japan's Otsuka has an IPO in the works. Bloomberg reports that Otsuka is prepping for a public offering that could take place by year's end--and could raise beaucoup capital for the drugmaker. As
Otsuka to arm sales reps with 1,300 iPads
First it was pharma iPhone apps for doctors. Now it's iPads for pharma reps. Otsuka Pharmaceutical is loading up on the Apple gadgets, aiming to help its sales reps deliver the latest drug info to
Otsuka puts off broadening use of Abilify
Otsuka Pharmaceutical yanked its European application for broader use of Abilify; it had asked the EMEA for permission to market the antipsychotic drug as a treatment for depression. Report
U.S. pharma looks to Japan as Japan eyes U.S.
Funny that some U.S. pharma companies are eyeing Japan as a growth market, considering that Japanese drugmakers are looking to grow everywhere but home. As the Financial Times points out today, the
Bristol pays $400M for Abilify lifeline
Few drugmakers are expected to have a year as tough as Bristol-Myers Squibb's 2012. Like the Mayan calendar, time would run out in 2012 on two of Bristol's blockbuster meds: Plavix and Abilify. And
